Rempart Asset Management Inc. Has $20.52 Million Position in Colgate-Palmolive (NYSE:CL)

Rempart Asset Management Inc. grew its holdings in Colgate-Palmolive (NYSE:CL) by 0.5% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 266,320 shares of the company’s stock after purchasing an additional 1,455 shares during the quarter. Colgate-Palmolive makes up 4.3% of Rempart Asset Management Inc.’s portfolio, making the stock its 8th biggest position. Rempart Asset Management Inc.’s holdings in Colgate-Palmolive were worth $20,517,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of CL. Beaumont Financial Advisors LLC increased its position in shares of Colgate-Palmolive by 2.7% during the first quarter. Beaumont Financial Advisors LLC now owns 4,842 shares of the company’s stock valued at $364,000 after acquiring an additional 127 shares during the last quarter. NorthRock Partners LLC grew its holdings in shares of Colgate-Palmolive by 4.7% in the first quarter. NorthRock Partners LLC now owns 2,824 shares of the company’s stock valued at $212,000 after purchasing an additional 128 shares in the last quarter. Rowland & Co. Investment Counsel ADV grew its holdings in shares of Colgate-Palmolive by 3.7% in the first quarter. Rowland & Co. Investment Counsel ADV now owns 3,695 shares of the company’s stock valued at $278,000 after purchasing an additional 133 shares in the last quarter. Gladstone Institutional Advisory LLC grew its holdings in shares of Colgate-Palmolive by 2.1% in the first quarter. Gladstone Institutional Advisory LLC now owns 6,329 shares of the company’s stock valued at $476,000 after purchasing an additional 133 shares in the last quarter. Finally, Sigma Investment Counselors Inc. grew its holdings in shares of Colgate-Palmolive by 4.9% in the first quarter. Sigma Investment Counselors Inc. now owns 3,152 shares of the company’s stock valued at $237,000 after purchasing an additional 146 shares in the last quarter. Institutional investors own 78.36% of the company’s stock.

Colgate-Palmolive Stock Down 0.4 %

Shares of NYSE:CL traded down $0.29 during trading on Friday, hitting $73.17. 5,597,119 shares of the company were exchanged, compared to its average volume of 4,691,457. The stock has a market capitalization of $60.49 billion, a P/E ratio of 40.65, a PEG ratio of 3.10 and a beta of 0.50. The company has a debt-to-equity ratio of 28.43, a current ratio of 1.17 and a quick ratio of 0.73. Colgate-Palmolive has a 12-month low of $67.84 and a 12-month high of $82.09. The firm’s 50 day moving average price is $75.06 and its 200-day moving average price is $75.83.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 28th. The company reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.75 by $0.02. The business had revenue of $4.82 billion during the quarter, compared to the consensus estimate of $4.70 billion. Colgate-Palmolive had a net margin of 8.02% and a return on equity of 386.76%. The company’s revenue was up 7.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.72 EPS. On average, research analysts predict that Colgate-Palmolive will post 3.17 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, November 15th. Stockholders of record on Monday, October 23rd will be issued a $0.48 dividend. The ex-dividend date is Friday, October 20th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.62%. Colgate-Palmolive’s payout ratio is 106.67%.

Analyst Ratings Changes

CL has been the subject of a number of research reports. Royal Bank of Canada restated a “sector perform” rating and issued a $83.00 price objective on shares of Colgate-Palmolive in a report on Monday, July 31st. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Monday, September 11th. Barclays lifted their price objective on shares of Colgate-Palmolive from $77.00 to $81.00 and gave the company an “equal weight” rating in a report on Tuesday, August 1st. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Colgate-Palmolive from $88.00 to $91.00 and gave the company a “buy” rating in a report on Monday, July 31st. Five analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $85.33.

Insider Activity

In other news, insider Jennifer Daniels sold 24,704 shares of Colgate-Palmolive stock in a transaction on Monday, September 11th. The shares were sold at an average price of $73.31, for a total value of $1,811,050.24. Following the transaction, the insider now directly owns 52,813 shares of the company’s stock, valued at approximately $3,871,721.03. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CEO Noel R. Wallace sold 48,627 shares of Colgate-Palmolive stock in a transaction on Monday, September 11th. The shares were sold at an average price of $73.37, for a total value of $3,567,762.99. Following the transaction, the chief executive officer now directly owns 246,969 shares of the company’s stock, valued at approximately $18,120,115.53. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jennifer Daniels sold 24,704 shares of the business’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $73.31, for a total transaction of $1,811,050.24. Following the completion of the transaction, the insider now directly owns 52,813 shares in the company, valued at $3,871,721.03. The disclosure for this sale can be found here. Insiders have sold 105,501 shares of company stock valued at $7,838,332 in the last ninety days. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.